Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company's lead asset...
Leadership
Carmine N. Stengone MBA, MS
President, CEO & Director
Peter T. Slover CPA
Chief Financial Officer
Timothy R. Watkins M.D., M.Sc.
Chief Medical Officer & Head of Development
Morgan Paulsen
Senior Manager of Accounting
Daniel S. Lorrain Ph.D.
Chief Science Officer
Steve E. Kunszabo
Senior Director of Investor Relations & Corporate Communications
